DE2139310C3 - Verfahren zur Herstellung von L-Pyroglutamyl-L-histidyl-L-prolinamid - Google Patents
Verfahren zur Herstellung von L-Pyroglutamyl-L-histidyl-L-prolinamidInfo
- Publication number
- DE2139310C3 DE2139310C3 DE19712139310 DE2139310A DE2139310C3 DE 2139310 C3 DE2139310 C3 DE 2139310C3 DE 19712139310 DE19712139310 DE 19712139310 DE 2139310 A DE2139310 A DE 2139310A DE 2139310 C3 DE2139310 C3 DE 2139310C3
- Authority
- DE
- Germany
- Prior art keywords
- solution
- temperature
- prolinamide
- trh
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 14
- 238000002360 preparation method Methods 0.000 title claims description 3
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 title description 19
- 239000000243 solution Substances 0.000 claims description 13
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 5
- 238000006345 epimerization reaction Methods 0.000 claims description 5
- 239000003112 inhibitor Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- CSKSDAVTCKIENY-WCCKRBBISA-N (2s)-pyrrolidine-2-carboxamide;hydrochloride Chemical compound Cl.NC(=O)[C@@H]1CCCN1 CSKSDAVTCKIENY-WCCKRBBISA-N 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 17
- 102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 229960002885 histidine Drugs 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical group ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- XFWCSGJOVUQCME-YUMQZZPRSA-N pEH Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NC(=O)CC1)C1=CNC=N1 XFWCSGJOVUQCME-YUMQZZPRSA-N 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- ZKGMBAZWQLUSMW-VKHMYHEASA-N (2,3,4,5,6-pentachlorophenyl) (2s)-5-oxopyrrolidine-2-carboxylate Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1OC(=O)[C@H]1NC(=O)CC1 ZKGMBAZWQLUSMW-VKHMYHEASA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000627 Thyrotropin-Releasing Hormone Substances 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012746 preparative thin layer chromatography Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical class OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- -1 pentachlorophenyl Chemical group 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 108010087791 pyroglutamylhistidine Proteins 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6179070A | 1970-08-06 | 1970-08-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2139310A1 DE2139310A1 (de) | 1972-02-10 |
| DE2139310B2 DE2139310B2 (de) | 1973-07-26 |
| DE2139310C3 true DE2139310C3 (de) | 1974-03-14 |
Family
ID=22038158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712139310 Expired DE2139310C3 (de) | 1970-08-06 | 1971-08-05 | Verfahren zur Herstellung von L-Pyroglutamyl-L-histidyl-L-prolinamid |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS4917264B1 (OSRAM) |
| AU (1) | AU449817B2 (OSRAM) |
| CA (1) | CA953710A (OSRAM) |
| DE (1) | DE2139310C3 (OSRAM) |
| FR (1) | FR2104025A5 (OSRAM) |
| GB (1) | GB1362696A (OSRAM) |
| SE (1) | SE375301B (OSRAM) |
-
1971
- 1971-07-08 CA CA117,749A patent/CA953710A/en not_active Expired
- 1971-07-13 AU AU31148/71A patent/AU449817B2/en not_active Expired
- 1971-07-30 GB GB3606371A patent/GB1362696A/en not_active Expired
- 1971-08-03 SE SE994771A patent/SE375301B/xx unknown
- 1971-08-05 JP JP46058753A patent/JPS4917264B1/ja active Pending
- 1971-08-05 DE DE19712139310 patent/DE2139310C3/de not_active Expired
- 1971-08-05 FR FR7128806A patent/FR2104025A5/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1362696A (en) | 1974-08-07 |
| DE2139310B2 (de) | 1973-07-26 |
| CA953710A (en) | 1974-08-27 |
| DE2139310A1 (de) | 1972-02-10 |
| AU3114871A (en) | 1973-01-18 |
| JPS4917264B1 (OSRAM) | 1974-04-27 |
| FR2104025A5 (OSRAM) | 1972-04-14 |
| AU449817B2 (en) | 1974-06-20 |
| SE375301B (OSRAM) | 1975-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0371262B1 (de) | Neue Digoxigenin-Derivate und ihre Verwendung | |
| DE2139310C3 (de) | Verfahren zur Herstellung von L-Pyroglutamyl-L-histidyl-L-prolinamid | |
| DE69107098T2 (de) | 2'-Deoxy-2'-Methylidenecytidin-dihydrat, Verfahren zu ihrer Herstellung und Mischmaterial. | |
| DE69828166T2 (de) | Verfahren zur herstellung von mit radioaktivem iod markierten, neurorezeptor-wirksamen mitteln | |
| DE1287578B (de) | Verfahren zum voruebergehenden Schutz von Carboxylgruppen | |
| DE2638555C3 (de) | Verfahren zur Herstellung von Pantethin | |
| DE2902292C2 (de) | Verfahren zur Herstellung von 2,4-Diaminobuttersäure oder 4-Amino-2-hydroxybuttersäure | |
| DE2512583B2 (de) | Verfahren zur Herstellung von e N-( γ -Glutamyl)lysin | |
| DE2324993C3 (de) | 4'-dehydro-oleandrin, verfahren zu dessen herstellung sowie ein diese verbindung enthaltendes pharmazeutisches praeparat | |
| DE925064C (de) | Verfahren zur Trennung der Komponenten des Actinomycins C | |
| DE2522224C3 (de) | Jodierte Cholesterin-Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltendes Mittel | |
| DE1196650B (de) | Verfahren zur Herstellung von 6-Methylen-6-desoxy-6-desmethyl-5-oxytetracyclin | |
| DE69013332T2 (de) | N-(3',4'-dimethoxyzimtsäure)anthranilsäure. | |
| CH363350A (de) | Verfahren zur Herstellung von Polyamiden | |
| DE3639583A1 (de) | Verfahren zum erzeugen des apovincaminsaeureethylesters | |
| DE812670C (de) | Verfahren zur Herstellung von Salzen der Salicylsaeure mit Morpholin oder dessen Homologen | |
| DE1493975A1 (de) | C-Chlor-Derivate von Aminosaeuren und Verfahren zu ihrer Herstellung | |
| DE2754292A1 (de) | Verfahren zur reinigung von steroiden | |
| DE977519C (de) | Verfahren zur Herstellung von 1-Phenyl-2-dihalogenacetamino-1, 3-propandiolen | |
| DE750481C (de) | Verfahren zur Herstellung von in waessrigen Loesungen bestaendigen Abkoemmlingen des2-Methyl-4-amino-naphthols-(1) | |
| DE1959064C3 (de) | Verfahren zur Herstellung von durch Deuterium oder Tritium substituierten Cardenoliden und Cardenolidglykosiden | |
| AT250558B (de) | Verfahren zur Herstellung von α-Glykosiden | |
| DE1470196C (de) | 1 Hydroxymethyl colchicindenvate und Verfahren zu ihrer Herstellung | |
| DE2402231B2 (de) | Verfahren zur herstellung von 4- acetamidophenyl-2-acetoxybenzoat | |
| DE2149197A1 (de) | Aminoderivate von Penicillinen und Verfahren zu deren Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| E77 | Valid patent as to the heymanns-index 1977 | ||
| 8339 | Ceased/non-payment of the annual fee |